USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NORWELL, INC.
Address:
415 JACKSON HILL ST
HOUSTON, TX
Phone:
N/A
URL:
N/A
EIN:
145971385
DUNS:
787111090
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $531,752.00 1
SBIR Phase II $2,923,479.00 1

Award List:

Development, Production and Evaluation of a Multivalent Adenoviral Plague Vaccine

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$531,752.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The final objective of this effort is to construct and test a multivalent adenoviral vaccine candidate that elicits a potent immune response against Yersinia pestis, the causative agent of plague. The proposed work is a collaborative effort between the… More

Evaluation and Production of a Multivalent Adenoviral Plague Vaccine

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$2,923,479.00
Agency:
HHS
Principal Investigator:
Eric Rothe – 832-483-1790
Abstract:
DESCRIPTION (provided by applicant): The final objective of this Phase II SBIR is to complete preclinical studies of a trivalent adenoviral vaccine against plague in preparation for human clinical trials. The plague vaccine project was selected in responseto the growing concern surrounding the… More